CNPR, NAPSR Exam
"Pull through" refers to: - ANS -generating demand for your company's product
\"Pull through" refers to: - ANS -generating demand for your company's product
\(T/F) Pharmaceutical development is a high risk undertaking that often proves disappointing. - ANS -True
\3,070 new meds are in development for cancer. - ANS -True
\5 rights of drug administration - ANS -Right dose, right patient, right medication, right route of administration, right time of
delivery
\6 stages of brand strategy - ANS -Brand positioning, brand personality, brand values, unique values of the brand that
support the values, how the brand appears to its audience, internal commitment
\6 stages of brand strategy - ANS -Brand positioning, brand personality, brand values, unique values of the brand that
support the values, how the brand appears to its audience, internal commitment
\A _____ is an inactive medication with no treatment value, used in experimental studies. - ANS -placebo
\A _____ is an inactive medication with no treatment value, used in experimental studies. - ANS -placebo
\A formulary is a list of prescription drugs approved by insurance coverage. - ANS -true
\A formulary is a list of prescription drugs approved by insurance coverage. - ANS -true
\A generic drug is ______ to the originator brand-name drug in dosage, strength, safety, and quality. - ANS -bioequivalent
\A generic drug is ______ to the originator brand-name drug in dosage, strength, safety, and quality. - ANS -bioevuivalent
\A low supply of oxygen due to low blood flow is - ANS -ischemia
\A low supply of oxygen due to low blood flow is: - ANS -ischemia
\A OBR - ANS -products for which there are no known or suspected bioequivalence problems
\A patent owner has the right to exclude others from making, using, selling or importing into the US the ____ it describes. -
ANS -invention
\A patent owner has the right to exclude others from making, using, selling or importing into the US the ____ it describes. -
ANS -invention
\A sample closet or cabinet is essentially similar to a grocery store shelf. The more visibility you can give your drug, the
more likely it will be used. - ANS -True
,\A site in the body which generally resides on a cell surface or within the cytoplasm. When stimulated or occupied, a
biological change/activity takes place: - ANS -receptor
\A site in the body which generally resides on a cell surface or within the cytoplasm. When stimulated or occupied, a
biological change/activity takes place: - ANS -receptor
\A substance that enhances the action of a drug or antigen: - ANS -adjuvant
\A substance that enhances the action of a drug or antigen: - ANS -adjuvant
\A term used to refer to drugs that are non-biological (that is, chemical) in nature: - ANS -small molecule
\A type of blood cell that helps the body fight infection and disease: - ANS -white blood cell
\A type of blood cell that helps the body fight infection and disease: - ANS -white blood cell
\AA OBR - ANS -products in conventional dosage forms with no bioequivalence problems
\Absorption - ANS -How the drug passes from its side of administration into the bloodstream
\Absorption methods - ANS -Oral, Buccal, sublingual, rectal, subcutaneous, intramuscular, transdermal, topical, inhalation,
intravenous
\Absorption methods - ANS -Oral, Buccal, sublingual, rectal, subcutaneous, intramuscular, transdermal, topical, inhalation,
intravenous
\According to the text, depression is a disease that attacks the: - ANS -central nervous system
\According to the text, depression is a disease that attacks the: - ANS -central nervous system
\According to the text, there are ___ classes of therapeutic drugs - ANS -US federal govt
\According to the text, there are ___ classes of therapeutic drugs. - ANS -US federal govt
\According to the text, which of the following is considered "going to the next level?" - ANS -staying focused
\According to the text, which of the following is considered "going to the next level?" - ANS -staying focused
\Acute medications, such as antibiotics, are used to address short-term illnesses or symptoms. - ANS -true
\Acute medications, such as antibiotics, are used to address short-term illnesses or symptoms. - ANS -true
\Adendovirus - ANS -This vector has a large capacity for foreign genes.
\Adendovirus - ANS -This vector has a large capacity for foreign genes.
\Adjuvants - ANS -a substance that enhances the actions of drug antigen; second form of treatment in addition to primary
care examples: chemo in addition to surgery
\Adjuvants - ANS -pg 110
, \Almost 98% of employed Americans are now covered by a HMO, a preferred provider organization, or a point-of-service
plan. - ANS -false
\Almost 98% of employed Americans are now covered by a HMO, a preferred provider organization, or a point-of-service
plan. - ANS -false
\Almost 98% of employed Americans are now covered by a HMO, a preferred provider organization, or a point-of-service
plan. - ANS -false
\Almost 98% of employed Americans are now covered by a HMO, a preferred provider organization, or a point-of-service
plan. - ANS -false
\AMA - ANS -provides ethical guidelines to physicians about appropriate interactions with pharmaceutical companies
\AMA - ANS -provides ethical guidelines to physicians about appropriate interactions with pharmaceutical companies
\AMA Gift guidelines - ANS -Pg 165
\AMA gift Guidelines - ANS -pg 231
\Among the biotechnology medications under development, about _____ target cancer. - ANS -50%
\Among the biotechnology medications under development, about _____ target cancer. - ANS -50%
\AN OBR - ANS -solutions and powders
\Anatomy - ANS -The study of basic structures of the body
\ANDA - ANS -abbreviated new drug application
\Another name for biologic compound is: - ANS -large molecule
\Another name for biologic compound is: - ANS -large molecule
\Any gifts accepted by physicians individually should entail a benefit to the patient and not be of substantial value - ANS
-true
\Any gifts accepted by physicians individually should entail a benefit to the patient and not be of substantial value - ANS
-True
\AO OBR - ANS -Injectable oil solutions
\AP - ANS -injectable aqueous solutions
\Areas of drug elimination and excretion - ANS -Lungs, breast milk, sweat tears urine feces, bile, saliva, and exhaled air
\Asymptomatic - ANS -Without signs or symptoms
\AT - ANS -topical products
"Pull through" refers to: - ANS -generating demand for your company's product
\"Pull through" refers to: - ANS -generating demand for your company's product
\(T/F) Pharmaceutical development is a high risk undertaking that often proves disappointing. - ANS -True
\3,070 new meds are in development for cancer. - ANS -True
\5 rights of drug administration - ANS -Right dose, right patient, right medication, right route of administration, right time of
delivery
\6 stages of brand strategy - ANS -Brand positioning, brand personality, brand values, unique values of the brand that
support the values, how the brand appears to its audience, internal commitment
\6 stages of brand strategy - ANS -Brand positioning, brand personality, brand values, unique values of the brand that
support the values, how the brand appears to its audience, internal commitment
\A _____ is an inactive medication with no treatment value, used in experimental studies. - ANS -placebo
\A _____ is an inactive medication with no treatment value, used in experimental studies. - ANS -placebo
\A formulary is a list of prescription drugs approved by insurance coverage. - ANS -true
\A formulary is a list of prescription drugs approved by insurance coverage. - ANS -true
\A generic drug is ______ to the originator brand-name drug in dosage, strength, safety, and quality. - ANS -bioequivalent
\A generic drug is ______ to the originator brand-name drug in dosage, strength, safety, and quality. - ANS -bioevuivalent
\A low supply of oxygen due to low blood flow is - ANS -ischemia
\A low supply of oxygen due to low blood flow is: - ANS -ischemia
\A OBR - ANS -products for which there are no known or suspected bioequivalence problems
\A patent owner has the right to exclude others from making, using, selling or importing into the US the ____ it describes. -
ANS -invention
\A patent owner has the right to exclude others from making, using, selling or importing into the US the ____ it describes. -
ANS -invention
\A sample closet or cabinet is essentially similar to a grocery store shelf. The more visibility you can give your drug, the
more likely it will be used. - ANS -True
,\A site in the body which generally resides on a cell surface or within the cytoplasm. When stimulated or occupied, a
biological change/activity takes place: - ANS -receptor
\A site in the body which generally resides on a cell surface or within the cytoplasm. When stimulated or occupied, a
biological change/activity takes place: - ANS -receptor
\A substance that enhances the action of a drug or antigen: - ANS -adjuvant
\A substance that enhances the action of a drug or antigen: - ANS -adjuvant
\A term used to refer to drugs that are non-biological (that is, chemical) in nature: - ANS -small molecule
\A type of blood cell that helps the body fight infection and disease: - ANS -white blood cell
\A type of blood cell that helps the body fight infection and disease: - ANS -white blood cell
\AA OBR - ANS -products in conventional dosage forms with no bioequivalence problems
\Absorption - ANS -How the drug passes from its side of administration into the bloodstream
\Absorption methods - ANS -Oral, Buccal, sublingual, rectal, subcutaneous, intramuscular, transdermal, topical, inhalation,
intravenous
\Absorption methods - ANS -Oral, Buccal, sublingual, rectal, subcutaneous, intramuscular, transdermal, topical, inhalation,
intravenous
\According to the text, depression is a disease that attacks the: - ANS -central nervous system
\According to the text, depression is a disease that attacks the: - ANS -central nervous system
\According to the text, there are ___ classes of therapeutic drugs - ANS -US federal govt
\According to the text, there are ___ classes of therapeutic drugs. - ANS -US federal govt
\According to the text, which of the following is considered "going to the next level?" - ANS -staying focused
\According to the text, which of the following is considered "going to the next level?" - ANS -staying focused
\Acute medications, such as antibiotics, are used to address short-term illnesses or symptoms. - ANS -true
\Acute medications, such as antibiotics, are used to address short-term illnesses or symptoms. - ANS -true
\Adendovirus - ANS -This vector has a large capacity for foreign genes.
\Adendovirus - ANS -This vector has a large capacity for foreign genes.
\Adjuvants - ANS -a substance that enhances the actions of drug antigen; second form of treatment in addition to primary
care examples: chemo in addition to surgery
\Adjuvants - ANS -pg 110
, \Almost 98% of employed Americans are now covered by a HMO, a preferred provider organization, or a point-of-service
plan. - ANS -false
\Almost 98% of employed Americans are now covered by a HMO, a preferred provider organization, or a point-of-service
plan. - ANS -false
\Almost 98% of employed Americans are now covered by a HMO, a preferred provider organization, or a point-of-service
plan. - ANS -false
\Almost 98% of employed Americans are now covered by a HMO, a preferred provider organization, or a point-of-service
plan. - ANS -false
\AMA - ANS -provides ethical guidelines to physicians about appropriate interactions with pharmaceutical companies
\AMA - ANS -provides ethical guidelines to physicians about appropriate interactions with pharmaceutical companies
\AMA Gift guidelines - ANS -Pg 165
\AMA gift Guidelines - ANS -pg 231
\Among the biotechnology medications under development, about _____ target cancer. - ANS -50%
\Among the biotechnology medications under development, about _____ target cancer. - ANS -50%
\AN OBR - ANS -solutions and powders
\Anatomy - ANS -The study of basic structures of the body
\ANDA - ANS -abbreviated new drug application
\Another name for biologic compound is: - ANS -large molecule
\Another name for biologic compound is: - ANS -large molecule
\Any gifts accepted by physicians individually should entail a benefit to the patient and not be of substantial value - ANS
-true
\Any gifts accepted by physicians individually should entail a benefit to the patient and not be of substantial value - ANS
-True
\AO OBR - ANS -Injectable oil solutions
\AP - ANS -injectable aqueous solutions
\Areas of drug elimination and excretion - ANS -Lungs, breast milk, sweat tears urine feces, bile, saliva, and exhaled air
\Asymptomatic - ANS -Without signs or symptoms
\AT - ANS -topical products
